Stock Taper
LAB
STANDARD BIOTOOLS INC.
NASDAQ
$0.69
▲ UP 1.72% (0.01)

KEY STATISTICS

Market Cap$265.49 M
52w High$1.72
52w Low$0.63
Dividend Yield
Frequency
P/E-9.79
Volume1.76M
Shares Out.391.46M

COMPANY

LEADERSHIP

Michael Egholm
CHIEF EXECUTIVE
Michael Egholm

COMPENSATION 2026

Salary$680,256
Stock Awards$5,337,883
Incentive Plan Pay$1,120,000
All Other Comp.$14,000
Total$8,823,502

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 10, 2011
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
387

PRICE TARGET

Target High$3.25
Target Low$3.25
Target Median$3.25
Target Consensus$3.25

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$18.80M
NOV
3
TUE

PRICE

$0.69 ▲ UP 1.72% (+$0.01)
$0.67$0.68$0.699:31 AM10:36 AM11:40 AM12:45 PM1:50 PM2:54 PM3:59 PM0.69

About Standard BioTools Inc.

https://www.standardbio.com ↗

Standard BioTools Inc. develops and sells proteomics and genomics instruments, consumables, and services globally, including platforms like SomaScan and CyTOF, for biomedical research and therapeutic development.

INDUSTRY

Medical - Specialties

A PRODUCT STANDARD BIOTOOLS INC. IS KNOWN FOR

Hyperion XTi Imaging System
Hyperion XTi Imaging System

The Hyperion XTi Imaging System uses Imaging Mass Cytometry to analyze over 40 biomarkers simultaneously on tissue samples, offering high-speed, automated, multiplexed imaging for deep spatial insights in oncology and immunology research.

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$13.8M $9.95M $15.45M $14.52M
Consumables$8.71M $2.63M $10.98M $9.38M
Service and Other Revenue$5.75M $11.83M $5.69M $5.59M
Instruments$5.09M $7.32M $4.47M $5.13M

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
EMEA$7.25M $7.01M $9.36M $8.62M
Americas$7.84M $0 $7.75M $7.65M
Asia Pacific$4.46M $1.16M $4.04M $3.83M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

OFFICER: CHIEF FINANCIAL OFFICER
Kim Hanjoon Alex
Sale · 28.2K shares
2026-08-20
DIRECTOR, OFFICER: PRESIDENT & CEO
Egholm Michael
Sale · 97.6K shares
2026-08-20
OFFICER: SVP & CHIEF BUSINESS OFFICER
Mackay Sean
Sale · 25.7K shares
2026-08-20
DIRECTOR, OFFICER: PRESIDENT & CEO
Egholm Michael
Sale · 362.6K shares
2026-08-03

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 1
1 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
CGEM$22.25COMPARE
BVS$14.25COMPARE
CBLL$24.62COMPARE
VREX$18.51COMPARE
CTKB$4.67COMPARE
KIDS$22.38COMPARE
SY$2.73COMPARE
TMCI$4.84COMPARE